Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
English
Español
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Modulation of CXCL14 (BRAK) expression in prostate cancer
Steven R. Schwarze
, Jun Luo
, William B. Isaacs
, David F. Jarrard
Health and Clinical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
90
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Modulation of CXCL14 (BRAK) expression in prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Prostate Cancer
100%
Neoplasm
50%
Cancer Growth
50%
Xenograft
50%
Messenger RNA
50%
Serositis
25%
Malignant Neoplasm
25%
Cytokine
25%
Angiogenesis
25%
Prostate Tumor
25%
Gleason Score
25%
Tumor Progression
25%
Upregulation
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Stromal Cell
25%
Cancer Inhibition
25%
Benign Prostatic Hyperplasia
25%
Immunohistochemistry
25%
RNA Hybridization
25%
Prostate Epithelium
25%
Chemokine
25%
Complementary DNA
25%
Biochemistry, Genetics and Molecular Biology
CXCL14
100%
Tumor Progression
20%
Messenger RNA
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
RNA
10%
Stromal Cell
10%
Upregulation
10%
Gleason Score
10%
RNA Hybridization
10%
Angiogenesis
10%
Cytokine
10%
Chemokine
10%
Growth Inhibition
10%
Immunology and Microbiology
CXCL14
100%
Xenograft
20%
Prostate
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Upregulation
10%
Gleason Score
10%
Prostate Epithelium
10%
RNA Hybridization
10%
Cytokine
10%
Growth Inhibition
10%
Angiogenesis
10%
Chemokine
10%
Ribonucleic Acid
10%